Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer

Baraibar, I; Melero, I; Ponz-Sarvise, M; Castanon, E

Castanon, E (reprint author), Univ Navarra, Dept Oncol Clin, Pamplona, Spain.

DRUG SAFETY, 2019; 42 (2): 281